One-pot, two-step synthesis of substituted triazoloquinoxalinone starting from 3-hydrazineylquinoxalin-2(1H)-one

References

• (a) Kalaria, P. N.; Karad, S. C.; Raval, D. K.. A Review on Diverse Heterocyclic Compounds as the Privileged Scaffolds in Antimalarial Drug Discovery. Eur. J. Med. Chem. 2018, 158, 917–936. DOI: 10.1016/j.ejmech.2018.08.040.
   PubMed Web of Science ®Google Scholar
  (b) Arora, P.; Arora, V.; Lamba, H. S.; Wadhwa, D.; IJPSR, 2012, 3, 2947–2954.
   Google Scholar
  (c) Lee, S.; Cil, O.; Diez-Cecilia, E.; Anderson, M. O.; Verkman, A. S. Nanomolar-Potency 1,2,4-Triazoloquinoxaline Inhibitors of the Kidney Urea Transporter UT-A1. J. Med. Chem. 2018, 61, 3209–3217. DOI: 10.1021/acs.jmedchem.8b00343.
   PubMed Web of Science ®Google Scholar
  (d) Klein, J. D.; Sands, J. M. Curr. Opin. Nephrol. Hypertens. 2016, 25, 444–451. DOI: 10.1097/MNH.0000000000000252.
   PubMed Web of Science ®Google Scholar
  (e) Smith, C. P. Mammalian Urea Transporters. Exp. Physiol. 2009, 94, 180–185. DOI: 10.1113/expphysiol.2008.043042.
   PubMed Web of Science ®Google Scholar
  (f) Baraldi, P. G.; Preti, D.; Materazzi, S.; Geppetti, P. Transient Receptor Potential Ankyrin 1 (TRPA1) Channel as Emerging Target for Novel Analgesics and anti-Inflammatory Agents. J. Med. Chem. 2010, 53, 5085–5107. DOI: 10.1021/jm100062h.
   PubMed Web of Science ®Google Scholar
  (g) Jaquemar, D.; Schenker, T.; Trueb, B. An Ankyrin-like Protein with Transmembrane Domains is Specifically Lost after Oncogenic Transformation of Human Fibroblasts. J. Biol. Chem. 1999, 274, 7325–7333. DOI: 10.1074/jbc.274.11.7325.
   PubMed Web of Science ®Google Scholar
  (h) Clapham, D. E. TRP Channels as Cellular Sensors. Nature. 2003, 426, 517–524. DOI: 10.1038/nature02196.
   PubMed Web of Science ®Google Scholar
  (i) Nilius, B. Mem. Acad. R. Med. Belg. 2007, 162, 244–253.
   Google Scholar
• Irfan, A.; Tahir, O. A.; Umer, M.; Ahmad, S.; Kousar, H. World J. Pharm. Pharm. Sci. 2017, 6, 11–30.
   Google Scholar
• (a) Kaizawa, H.; Sugita, M.; Azami, H.; Seo, R.; Nomura, T.; Yamamoto, S.; Yamamoto, H.; Tsuchiya, K.; Kubota, H.; Kamijo, K. Tokyo (JP), US008357688 B2, 2010.
   Google Scholar
  (b) Alswah, M.; Ghiaty, A.; El-Morsy, A.; El-Gamal, K. Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3- A ]Quinoxaline Derivatives as Novel Anticonvulsant Agents. ISRN Organic Chem. 2013, 2013, 1–7. DOI: 10.1155/2013/587054.
   Google Scholar
  (c) Erez, U.; Frenk, H.; Goldberg, O.; Cohen, A.; Vivian, I.; Teichberg, V. I. Anticonvulsant Properties of 3-Hydroxy-2-Quinoxalinecarboxylic Acid, a Newly Found Antagonist of Excitatory Amino Acids. 1985. Eur. J. Pharm. 110, 31–39. DOI: 10.1016/0014-2999(85)90025-1.
   Google Scholar
  (d) Ohmori, J.; Sakamoto, S.; Kubota, H.; Shimizu-Sasamata, M.; Okada, M.; Kawasaki, S.; Hidaka, K.; Togami, J.; Furuya, T.; Murase, K. 6-(1H-Imidazol-1-yl)-7-Nitro-2,3(1H,4H)-Quinoxalinedione Hydrochloride (YM90K) and Related Compounds: Structure-Activity Relationships for the AMPA-Type non-NMDA Receptor. J. Med. Chem. 1994. 37, 467–475, DOI: 10.1021/jm00030a006.
   Google Scholar
• (a) Krishnan, V. S. H.; Chowdary, K. S. Indian J. Chem. 1999, 39B, 1371–1373.
   Google Scholar
  (b) Rashed, N.; Massry, A. M. E.; Sayed, H.; Ashry E.; Amer, A. A Facile Synthesis of Novel Triazoloquinoxahnones and triazinoquinoxalinones. J Heterocycl Chem. 1990, 27, 691, 694 DOI: 10.1002/jhet.5570270339.
   Web of Science ®Google Scholar
  (c) Ajani, O. O.; Nwinyi, O. C. Can. J. Pure. Appl. Sci. 2009, 3, 983–992.
   Google Scholar
• (a) Krishnan, V. S. H. Indian J. Heterocyclic Chem. 1994, 3, 227–232.
   Google Scholar
  (b) Krishnan, V. S. H. Indian J. Heterocyclic Chem. 2000, 39B, 329–333.
   Google Scholar
• Hutchinson, J. H.; La Jolla, CA.; Seiders, T. J.; Stearns B. A.; Wang, B.; San Diego, CA (US) US20070173508 A1, 2007.
   Google Scholar
• (a) Saranya, J.; Sounthari, P.; Kiruthika, A.; Saranya, G.; Yuvarani, S.; Parmeseari, K.; Chitra, S. Orient. J. Chem. 2014, 30, 1719–1736.
   Google Scholar
  (b) El-Adl, K.; El-Helby, A.-G. A.; Sakr, H.; Elwan, A. Design, Synthesis, Molecular Docking and anti-Proliferative Evaluations of [1,2,4]Triazolo[4,3-a]Quinoxaline Derivatives as DNA Intercalators and Topoisomerase II Inhibitors. Bioorg Chem. 2020, 105, 104399. DOI: 10.1016/j.bioorg.2020.104399.
   PubMed Web of Science ®Google Scholar
  (c) Huang, A.; Ma, C. Recent Progress in Biological Activities and Synthetic Methodologies of Pyrroloquinoxalines. MRMC. 2013, 13, 607–616. DOI: 10.2174/1389557511313040012.
   Web of Science ®Google Scholar
  (d) Kalinin, A. A.; Islamova, L. N.; Fazleeva, G. M. New Achievements in the Synthesis of Pyrrolo[1,2-a]Quinoxalines. Chem. Heterocycl. Comp. 2019, 55, 584–597. DOI: 10.1007/s10593-019-02501-w.
   Web of Science ®Google Scholar
  (e) Ramli, Y.; Moussaif, A.; Karrouchi, K.; Essassi, E. M. Journal of Chemistry 2014, 2014, Article ID 563406.
   Web of Science ®Google Scholar
  (f) Chouchou, A.; Patinote, C.; Cuq, P.; Bonnet, P.-A.; Deleuze-Masquéfa C. Imidazo[1,2-a]Quinoxalines Derivatives Grafted with Amino Acids: Synthesis and Evaluation on A375 Melanoma Cells. Molecules. 2018, 23, 2987. DOI: 10.3390/molecules23112987.
   Web of Science ®Google Scholar
  (g) Zghaib, Z.; Guichou, J.-F.; Vappiani, J.; Bec, N.; Hadj-Kaddour, K.; Vincent, L.-A.; Paniagua-Gayraud, S.; Larroque, C.; Moarbess, G.; Kassabi, I.; et al. New Imidazoquinoxaline Derivatives: Synthesis, Biological Evaluation on Melanoma, Effect on Tubulin Polymerization and Structure–Activity Relationships. Bioorg. Med. Chem. 2016, 24, 2433–2440 DOI: 10.1016/j.bmc.2016.04.004.
   PubMed Web of Science ®Google Scholar
  (h) Boraei, A. T. A.; Sarhan, A. A. M.; Yousuf, S.; Barakat, A. Molecules. 2020, 25, 450. DOI: 10.3390/molecules25030450.
   Web of Science ®Google Scholar
• Díaz, D. D.; Miranda, P. O.; Juan I.; Padrón, J. I; Martín, V. S. Recent Uses of Iron (III) Chloride in Organic Synthesis. Curr. Org. Chem. 2006, 10, 457–476. DOI: 10.2174/138527206776055330.
   Web of Science ®Google Scholar
• Sumran, G.: Aggarwal, R.; Mittal, A.; Aggarwal, A.; Gupta, A. Design, Synthesis and Photoinduced DNA Cleavage Studies of [1,2,4]-Triazolo[4,3-a]Quinoxalin-4(5H)-Ones. Bioorg. Chem. 2019, 88, 102932. DOI: 10.1016/j.bioorg.2019.102932.
   PubMed Web of Science ®Google Scholar